Table 1. Epidemiological and baseline data.
| Glaucoma patients | Patients with ocular hypertension (OHT) | Controls | |
|---|---|---|---|
| N | 44 | 11 | 70 |
| Gender n (%) | |||
| Men | 21 (47.7) | 7 (63.6) | 32 (45.7) |
| Women | 23 (52.3) | 4 (36.4) | 38 (54.3) |
| Age (years) | |||
| Mean (SD) | 65.0 (±11.0) | 51.0 (±12.4) | 38.2 (±25.0) |
| Median | 65.0 | 49.0 | 33.5 |
| Range | 55 to 75 | 33 to 77 | 3 to 86 |
| Eye n (%) | |||
| Right | 20 (45.5) | 5 (45.5) | 34 (48.6) |
| Left | 24 (54.5) | 6 (54.5) | 36 (51.4) |
| BCVA (logMAR) | |||
| Mean (SD) | 0.2 (±0.25) | 0.05 (±0.09) | 0.03 (±0.1) |
| Median | 0.1 | 0.0 | 0.0 |
| IOP (mmHg) | |||
| Mean (SD) | 17.9 (±7.5) | 15.0 (±3.7) | 17.2 (±3.4) |
| Median | 17.0 | 14.0 | 18.0 |
| Mean deviation (dB) of 30/2 visual field testing | |||
| Mean (SD) | −10.0 (±6.1) | −1.1 (±0.8) | − 0.6 (±1.6) |
| Median | −8.8 | −1.1 | −0.9 |
| Range | −24.9 to −0.9 | −2.1 to 0.2 | −2.8 to 5.3 |
| Aulhorn classification or glaucomatous scotoma n (%) | n/a | n/a | |
| Degree 1 | 12 (27.3) | ||
| Degree 2 | 12 (27.3) | ||
| Degree 3 | 10 (22.3) | ||
| Degree 4 | 8 (18.2) | ||
| Degree 5 | 2 (4.5) | ||
| Hodapp classification for glaucomatous scotoma n (%) | n/a | n/a | |
| Stage 1 | 14 (31.8) | ||
| Stage 2 | 15 (34.1) | ||
| Stage 3 | 15 (34.1) | ||
| Disc size in CSLT (mm2) | |||
| Mean (SD) | 2.71 (±0.80) | 2.95 (±0.41) | 2.98 (±0.41) |
| Range | 2.44–3.72 | 2.50–3.83 | 2.45–4.23 |
| BMO area in SD-OCT (mm2) | |||
| Mean (SD) | 2.71 (±0.80) | 2.40 (±0.44) | 2.50 (±0.40) |
| Range | 2.44–3.72 | 1.16–3.04 | 1.81–3.35 |
Abbreviations: BMO, Bruch’s membrane opening; CSLT, confocal scanning laser tomography; SD-OCT, spectral domain optical coherence tomography.